Results 11 to 20 of about 448,470 (384)

Understanding the Infodemic

open access: yesGlobal Rheumatology, 2021
The COVID-19 outbreak has been accompanied by what the WHO classifies as infodemic. Inaccurate information that disseminates through social networks and apps and has negative effects on the population.
Global Rheumatology by PANLAR
doaj   +1 more source

Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach

open access: yesNature Reviews Rheumatology, 2022
The four Janus kinase (JAK) proteins and seven signal transducer and activator of transcription (STAT) transcription factors mediate intracellular signal transduction downstream of cytokine receptors, which are implicated in the pathology of autoimmune ...
Yoshiya Tanaka   +3 more
semanticscholar   +1 more source

Obstacles facing the dissemination of science in Latin America

open access: yesGlobal Rheumatology, 2022
La difusión de la ciencia cumple un papel fundamental en dar a conocer el desarrollo y resultados de investigaciones científicas, en el contexto del conocimiento científico, tecnológico y por supuesto la innovación.
Global Rheumatology by PANLAR
doaj   +1 more source

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis

open access: yesAnnals of the Rheumatic Diseases, 2022
Objective To develop and validate revised classification criteria for granulomatosis with polyangiitis (GPA). Methods Patients with vasculitis or comparator diseases were recruited into an international cohort.
J. Robson   +10 more
semanticscholar   +1 more source

2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis

open access: yesArthritis & Rheumatology, 2023
The objective is to update recommendations for prevention and treatment of glucocorticoid‐induced osteoporosis (GIOP) for patients with rheumatic or nonrheumatic conditions receiving >3 months treatment with glucocorticoids (GCs) ≥2.5 mg daily.
M. B. Humphrey   +31 more
semanticscholar   +1 more source

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

open access: yesArthritis & Rheumatology, 2021
To develop updated guidelines for the pharmacologic management of rheumatoid arthritis.
L. Fraenkel   +36 more
semanticscholar   +1 more source

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

open access: yesArthritis & Rheumatology, 2019
To develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).
M. Aringer   +63 more
semanticscholar   +2 more sources

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids

open access: yesRheumatology, 2022
Centre for Rheumatic Diseases, King’s College London, London, UK Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK Department of Rheumatology, Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust ...
M. Russell   +23 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy